These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10841071)

  • 21. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
    Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nabumetone: new preparation. Just another NSAID.
    Prescrire Int; 2000 Apr; 9(46):43-6. PubMed ID: 11503785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of oral anticoagulation and hemarthrosis associated with nabumetone.
    Dennis VC; Thomas BK; Hanlon JE
    Pharmacotherapy; 2000 Feb; 20(2):234-9. PubMed ID: 10678303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety evaluation of nabumetone in United States clinical trials.
    Jackson RE; Mitchell FN; Brindley DA
    Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nabumetone--a new NSAID.
    Med Lett Drugs Ther; 1992 Apr; 34(868):38-40. PubMed ID: 1556995
    [No Abstract]   [Full Text] [Related]  

  • 26. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
    Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
    J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long-term U.S. study--a report on outcome and tolerance.
    Fleischmann R
    Eur J Rheumatol Inflamm; 1991; 11(3):50-3. PubMed ID: 1365481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerability of nabumetone in the treatment of painful symptomatology of rheumatoid arthritis and osteoarthrosis].
    Riccieri V; Spadaro A; Iagnocco A
    Clin Ter; 1991 May; 137(3):185-9. PubMed ID: 1831086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].
    Lemmel EM; Stroehmann I
    Fortschr Med; 1988 Apr; 106(12):253-6. PubMed ID: 3260888
    [No Abstract]   [Full Text] [Related]  

  • 30. Nabumetone (Relifex)--another NSAID.
    Drug Ther Bull; 1988 May; 26(11):41-3. PubMed ID: 3289871
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis.
    Fleischmann RM
    J Rheumatol Suppl; 1992 Nov; 36():32-40. PubMed ID: 1474533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the long-term safety experience of nabumetone.
    Willkens RF
    Drugs; 1990; 40 Suppl 5():34-7. PubMed ID: 2081490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A decision analysis model in the evaluation of NSAIDs in a managed care setting: a case study.
    Brixner DI
    Med Interface; 1994 Nov; 7(11):145-50. PubMed ID: 10138701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study.
    Blechman WJ
    Am J Med; 1987 Oct; 83(4B):70-3. PubMed ID: 3318432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nabumetone in the treatment of active adult rheumatoid arthritis.
    Brobyn RD
    Am J Med; 1987 Oct; 83(4B):50-4. PubMed ID: 3318429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
    Davies NM
    Clin Pharmacokinet; 1997 Dec; 33(6):404-16. PubMed ID: 9435990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
    Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of nabumetone in the treatment of osteoarthritis of the knee joint: an open trial.
    Ben Dallah SK; Lenghi M
    J Int Med Res; 1994; 22(4):218-24. PubMed ID: 7958381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology.
    Mangan FR; Flack JD; Jackson D
    Am J Med; 1987 Oct; 83(4B):6-10. PubMed ID: 3688000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worldwide safety experience with nabumetone.
    Bernhard GC
    J Rheumatol Suppl; 1992 Nov; 36():48-57. PubMed ID: 1474535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.